InvestorsHub Logo

fbg0316

05/30/17 8:07 AM

#21086 RE: CATTDOGG12347 #21076

Agreed, now we have Bristol, Astra and Merck collaborating with ADXS for potential combination licensing deals. This is positive. I still think we will see a monetary deal for AXAL in Europe soon given the company is about to apply for Europe monotherapy approval for cervical cancer but doesn't have a commercialization plan in place yet.

bill_y

05/30/17 8:15 AM

#21089 RE: CATTDOGG12347 #21076

don't see adxs-dual as a bms consolation..but as the company said..coming out of what has been learned in developing axal..